İstemihan, Z. Et Al. 2024. 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good. EASL Congress 2024 , (Milan, Italy), 803.

İstemihan, Z., Kemeç, G., Cebeci, T., Çetin, O., Genç Uluçeçen, S., Rüstemzade, A., ... Nurıyev, K.(2024). 10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good . EASL Congress 2024 (pp.803). Milan, Italy

İstemihan, Zülal Et Al. "10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good," EASL Congress 2024, Milan, Italy, 2024

İstemihan, Zülal Et Al. "10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good." EASL Congress 2024 , Milan, Italy, pp.803, 2024

İstemihan, Z. Et Al. (2024) . "10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good." EASL Congress 2024 , Milan, Italy, p.803.

@conferencepaper{conferencepaper, author={Zülal İSTEMİHAN Et Al. }, title={10-year results under tenofovir disoproxil fumarate and entecavir in chronic hepatitis B; HBV clearance rare, disease outcomes good}, congress name={EASL Congress 2024}, city={Milan}, country={Italy}, year={2024}, pages={803} }